From the essential role of vitamin D to groundbreaking findings on exhausted T-cells, this research is shedding light on ways to better understand, manage, and treat autoimmune conditions.

The progress seen at ACR 2024 is a testament to the power of research and collaboration. Discover more inside.

Cell therapy involves using a patient’s own cells or donor cells to reset the immune system.

The recent developments in biosimilars are creating waves in the world of rheumatology and beyond, offering promising solutions to improve patient care. However, understanding the complexities of these treatments and their integration into healthcare systems is crucial for ensuring their benefits are fully realized.

Breakthroughs in Sjogren’s disease and psoriatic arthritis treatments revealed at ACR Convergence 2024 promise improved care and quality of life for patients. The future of rheumatology is here!

For patients who have achieved remission or stable disease control, tapering medications can sometimes be a next step. Tapering is the process of gradually reducing the dosage or frequency of medication, with the goal of maintaining remission or low disease activity while minimizing the amount of medication needed.

ACR 2024 Conference Showcases Advances in Rheumatic Disease Treatments.

The 2024 American College of Rheumatology conference brought together researchers from around the world to share the latest findings on managing rheumatic diseases.